NeoStem Secures Debt Facility

NEW YORK, Sep 29, 2014 (GLOBE NEWSWIRE via COMTEX) Company Provides Update on Remaining Milestones for 2014 NeoStem, Inc. (Nasdaq:NBS) ( NeoStem or the Company ), a leader in the emerging cellular therapy industry, announced today that it has entered into a Loan and Security Agreement (the Loan Agreement ) with Oxford Finance LLC ( Oxford ) pursuant to which Oxford has agreed to make a term loan to the Company in the principal amount of up to $20 million, and has made the initial disbursement of $15 million. The loan matures in September 2018 and the additional $5 million disbursement is available in the event of the Company s consummation of a partnering transaction around the Company s NBS10 development program for post acute myocardial infarction ( AMI ) patients. Oxford will have a security interest in substantially all the Company s real and personal property, excluding intellectual property. No warrants or common stock were issued in connection with this financing. This new debt
http://bit.ly/1ryHsWc